FIGS Stock - FIGS, Inc.
Unlock GoAI Insights for FIGS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $555.56M | $545.65M | $505.83M | $419.59M | $263.11M |
| Gross Profit | $375.62M | $376.96M | $354.46M | $301.22M | $190.22M |
| Gross Margin | 67.6% | 69.1% | 70.1% | 71.8% | 72.3% |
| Operating Income | $2.27M | $34.05M | $37.67M | $10.98M | $57.94M |
| Net Income | $2.72M | $22.64M | $21.19M | $-9,556,000 | $49.76M |
| Net Margin | 0.5% | 4.1% | 4.2% | -2.3% | 18.9% |
| EPS | $0.02 | $0.13 | $0.13 | $-0.06 | $0.31 |
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States. It designs and sells healthcare apparel and other non-scrub offerings, such as lab coats, under scrubs, outerwear, activewear, loungewear, compression socks footwear, and masks. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests, and jackets. The company markets and sells its products through its digital platform comprising website and mobile app. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 7th 2025 | Telsey Advisory Group | Reiterated | Market Perform | $9← $7 |
| October 15th 2025 | BTIG Research | Initiation | Buy | $9 |
| August 8th 2025 | Telsey Advisory Group | Reiterated | Market Perform | $7← $5 |
| May 5th 2025 | Telsey Advisory Group | Reiterated | Market Perform | $5← $7 |
| August 9th 2024 | Telsey Advisory Group | Reiterated | Market Perform | $7← $6 |
| April 2nd 2024 | BofA Securities | Downgrade | Underperform | $4.5← $8.5 |
| March 8th 2024 | Oppenheimer | Downgrade | Perform | - |
| February 29th 2024 | Telsey Advisory Group | Downgrade | Market Perform | $6 |
| January 24th 2024 | Barclays | Upgrade | Equal Weight | $7 |
| July 17th 2023 | Raymond James | Downgrade | Market Perform | - |
| May 3rd 2023 | ROTH MKM | Initiation | Buy | $9 |
| May 2nd 2023 | Barclays | Downgrade | Underweight | - |
| November 11th 2022 | Raymond James | Downgrade | Outperform | $8← $12 |
| October 14th 2022 | Barclays | Downgrade | Equal Weight | $9← $15 |
| July 22nd 2022 | Piper Sandler | Initiation | Overweight | - |
Earnings History & Surprises
FIGSEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | $0.02 | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.02 | $0.05 | +150.0% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $0.02 | $0.04 | +100.0% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $-0.01 | $-0.00 | +93.7% | ✓ BEAT |
Q1 2025 | Feb 27, 2025 | $0.01 | $0.01 | 0.0% | = MET |
Q4 2024 | Nov 7, 2024 | $-0.01 | $-0.01 | -25.0% | ✗ MISS |
Q3 2024 | Aug 8, 2024 | $0.00 | $0.01 | +203.0% | ✓ BEAT |
Q2 2024 | May 9, 2024 | $0.00 | $0.01 | +338.6% | ✓ BEAT |
Q1 2024 | Feb 28, 2024 | $0.02 | $0.05 | +153.8% | ✓ BEAT |
Q4 2023 | Nov 2, 2023 | $0.02 | $0.03 | +30.4% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $0.01 | $0.02 | +140.1% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $0.00 | $0.01 | +223.6% | ✓ BEAT |
Q1 2023 | Feb 28, 2023 | $0.01 | $0.05 | +504.6% | ✓ BEAT |
Q4 2022 | Nov 10, 2022 | $0.02 | $0.02 | -2.4% | ✗ MISS |
Q3 2022 | Aug 4, 2022 | $0.02 | $0.03 | +76.5% | ✓ BEAT |
Q2 2022 | May 12, 2022 | $0.06 | $0.05 | -16.7% | ✗ MISS |
Q1 2022 | Mar 8, 2022 | $0.03 | $0.09 | +207.3% | ✓ BEAT |
Q4 2021 | Nov 10, 2021 | $0.02 | $0.03 | +56.3% | ✓ BEAT |
Q3 2021 | Aug 12, 2021 | $-0.21 | $-0.26 | -23.8% | ✗ MISS |
Latest News
BTIG Maintains Buy on FIGS, Raises Price Target to $15
📈 PositiveMorgan Stanley Maintains Equal-Weight on FIGS, Raises Price Target to $7.5
📈 PositiveBTIG Maintains Buy on FIGS, Raises Price Target to $12
📈 PositiveBarclays Maintains Equal-Weight on FIGS, Raises Price Target to $9
➖ NeutralGoldman Sachs Maintains Sell on FIGS, Raises Price Target to $5.5
📉 NegativeTelsey Advisory Group Maintains Market Perform on FIGS, Raises Price Target to $9
➖ NeutralMarket-Moving News for November 7th
➖ NeutralFIGS shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY25 sales guidance above estimates.
📈 PositiveBTIG Maintains Buy on FIGS, Raises Price Target to $10
📈 PositiveFIGS shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY25 sales guidance above estimates.
📈 PositiveFIGS Sees FY2025 Sales $594.447M vs $570.402M Est
📈 PositiveFIGS Q3 EPS $0.05 Beats $0.02 Estimate, Sales $151.661M Beat $142.518M Estimate
📈 PositiveTelsey Advisory Group Maintains Market Perform on FIGS, Maintains $7 Price Target
➖ NeutralBTIG Initiates Coverage On FIGS with Buy Rating, Announces Price Target of $9
📈 PositiveFrequently Asked Questions about FIGS
What is FIGS's current stock price?
What is the analyst price target for FIGS?
What sector is FIGS, Inc. in?
What is FIGS's market cap?
Does FIGS pay dividends?
Similar Stocks
Consumer Cyclical SectorExplore stocks similar to FIGS for comparison